For injection, fosapirtan dimeglumine combined with palonosetron hydrochloride and dexamethasone acetate: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
Esophagus Cancer	1
Lung Cancer	1

Recruiting trials involving For injection, fosapirtan dimeglumine combined with palonosetron hydrochloride and dexamethasone acetate

The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
NCT07617246 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve For injection, fosapirtan dimeglumine combined with palonosetron hydrochloride and dexamethasone acetate?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.